Contents
Sight’s analyzer machine, "OLO", performs a Complete Blood Count, a commonly ordered blood test. It can complete results in minutes. It’s compact: designed to be used in a mobile capacity.
Their analyzers create a digital version of blood, by capturing 1,000 highly detailed images of a finger prick sample, which is then interpreted by algorithms. Sight’s first product was focused on detecting Malaria, used in 24 countries, and has delivered almost 1 million tests to date.
History
Their OLO product came to fruition five years ago, with the introduction of Sight’s advanced algorithms to detect Malaria.
The solution enabled quick diagnoses using digital fluorescent microscopy and computer vision algorithms.
Timeline
No Timeline data yet.
Further Resources
Title
Author
Link
Type
Date
No Further Resources data yet.
References
Company attributes
Industry
B2X
CEO
Founder
Pitchbook URL
Date Incorporated
2020
Number of Employees (Ranges)
51 – 200
Full Address
23 Menahem Begin street, Tel Aviv, Israel 6618356, IL
Investors
DUNS Number
117708988
Founded Date
2011
Total Funding Amount (USD)
186,800,000
Latest Funding Round Date
August 2020
Glassdoor ID
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
71,000,000
